He, Liting et al. published their research in Chemical Communications (Cambridge, United Kingdom) in 2021 |CAS: 5036-48-6

The Article related to iridium complex mitochondrial topoisomerase inhibitor cisplatin resistant tumor cell, Pharmacology: Effects Of Neoplasm Inhibitors and Cytotoxic Agents and other aspects.Formula: C6H11N3

He, Liting; Xiong, Kai; Wang, Lili; Guan, Ruilin; Chen, Yu; Ji, Liangnian; Chao, Hui published an article in 2021, the title of the article was Iridium(III) complexes as mitochondrial topoisomerase inhibitors against cisplatin-resistant cancer cells.Formula: C6H11N3 And the article contains the following content:

Herein, we developed the first metal-based mitochondrial topoisomerase inhibitors to achieve an effective therapeutic outcome for the therapy of cisplatin-resistant tumor cells. The experimental process involved the reaction of N-(3-Aminopropyl)-imidazole(cas: 5036-48-6).Formula: C6H11N3

The Article related to iridium complex mitochondrial topoisomerase inhibitor cisplatin resistant tumor cell, Pharmacology: Effects Of Neoplasm Inhibitors and Cytotoxic Agents and other aspects.Formula: C6H11N3

Referemce:
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem